Efficacy of three lytic bacteriophages for eradicating biofilms of multidrug-resistant Proteus mirabilis
- PMID: 34559314
- DOI: 10.1007/s00705-021-05241-5
Efficacy of three lytic bacteriophages for eradicating biofilms of multidrug-resistant Proteus mirabilis
Abstract
Proteus mirabilis is one of the most frequent causes of catheter-associated urinary tract infections (CAUTIs) owing to its capability to colonize and develop crystalline multidrug-resistant (MDR) biofilms. Here, we report the isolation and partial characterization of three novel bacteriophages, vB_PmiM-ES1a, vB_PmiM-ES1b, and vB_PmiM-ES1c, which were active against the planktonic form and biofilms of the MDR P. mirabilis strain ES01, isolated from CAUTIs in Egypt. The antibiotic susceptibility profile of the P. mirabilis isolates showed resistance to most of the antibiotics tested. The isolated phages were identified morphologically using TEM, and each appeared to have myovirus-like morphology. The three phages displayed strong lytic activity and a narrow host range, and they were stable at different ranges of temperatures and pH values. One-step growth kinetics showed a lysis time of 180 min with a burst size of 99.6, 95, and 86 PFU/cell for phage vB_PmiM-ES1a, vB_PmiM-ES1b, and vB_PmiM-ES1c, respectively. The three phages exhibited different digestion patterns using different restriction enzymes. The genome size was estimated to be 59.39 kb, 62.19 kb, and 52.07 kb for phage vB_PmiM-ES1a, vB_PmiM-ES1b, and vB_PmiM-ES1c, respectively. A phage cocktail including the three phages showed a potential ability to reduce and eradicate a biofilm formed by the MDR Proteus mirabilis EG-ES1. Accordingly, a phage cocktail of vB_PmiM-ES1a, vB_PmiM-ES1b, and vB_PmiM-ES1c is considered a promising candidate for use as a biocontrol agent against MDR Proteus mirabilis bacteria.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Similar articles
-
Development of a Phage Cocktail to Control Proteus mirabilis Catheter-associated Urinary Tract Infections.Front Microbiol. 2016 Jun 28;7:1024. doi: 10.3389/fmicb.2016.01024. eCollection 2016. Front Microbiol. 2016. PMID: 27446059 Free PMC article.
-
A Phage Cocktail To Control Surface Colonization by Proteus mirabilis in Catheter-Associated Urinary Tract Infections.Microbiol Spectr. 2022 Oct 26;10(5):e0209222. doi: 10.1128/spectrum.02092-22. Epub 2022 Oct 4. Microbiol Spectr. 2022. PMID: 36194151 Free PMC article.
-
Isolation and Characterization of a Lytic Bacteriophage (vB_PmiS-TH) and Its Application in Combination with Ampicillin against Planktonic and Biofilm Forms of Proteus mirabilis Isolated from Urinary Tract Infection.J Mol Microbiol Biotechnol. 2018;28(1):37-46. doi: 10.1159/000487137. Epub 2018 Apr 4. J Mol Microbiol Biotechnol. 2018. PMID: 29617701
-
Proteus mirabilis Biofilm: Development and Therapeutic Strategies.Front Cell Infect Microbiol. 2020 Aug 14;10:414. doi: 10.3389/fcimb.2020.00414. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32923408 Free PMC article. Review.
-
Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.Ann Clin Microbiol Antimicrob. 2021 Apr 26;20(1):30. doi: 10.1186/s12941-021-00433-y. Ann Clin Microbiol Antimicrob. 2021. PMID: 33902597 Free PMC article. Review.
Cited by
-
Characterization, genome analysis and antibiofilm efficacy of lytic Proteus phages RP6 and RP7 isolated from university hospital sewage.Virus Res. 2023 Mar;326:199049. doi: 10.1016/j.virusres.2023.199049. Epub 2023 Jan 28. Virus Res. 2023. PMID: 36717023 Free PMC article.
-
Application of a novel lytic Jerseyvirus phage LPSent1 for the biological control of the multidrug-resistant Salmonella Enteritidis in foods.Front Microbiol. 2023 Apr 5;14:1135806. doi: 10.3389/fmicb.2023.1135806. eCollection 2023. Front Microbiol. 2023. PMID: 37089535 Free PMC article.
-
Bacteriophage P2-71: a promising therapeutic against multidrug-resistant Proteus mirabilis in urinary tract infections.Front Vet Sci. 2024 Sep 17;11:1445264. doi: 10.3389/fvets.2024.1445264. eCollection 2024. Front Vet Sci. 2024. PMID: 39376913 Free PMC article.
-
Isolation, biological and whole genome characteristics of a Proteus mirabilis bacteriophage strain.BMC Microbiol. 2023 Aug 8;23(1):215. doi: 10.1186/s12866-023-02960-4. BMC Microbiol. 2023. PMID: 37553593 Free PMC article.
-
Isolation and Characterization of Chi-like Salmonella Bacteriophages Infecting Two Salmonella enterica Serovars, Typhimurium and Enteritidis.Pathogens. 2022 Dec 6;11(12):1480. doi: 10.3390/pathogens11121480. Pathogens. 2022. PMID: 36558814 Free PMC article.
References
-
- Girlich D, Bonnin RA, Dortet L, Naas T (2020) Genetics of acquired antibiotic resistance genes in Proteus spp. Front Microbiol 11:1–21 - DOI
-
- Rózalski A, Sidorczyk Z, Kotełko K (1997) Potential virulence factors of Proteus bacilli. Microbiol Mol Biol Rev 61:65–89. https://doi.org/10.1128/.61.1.65-89.1997 - DOI - PubMed - PMC
-
- Shanmugam P, Jeya M, Linda SS (2013) The bacteriology of diabetic foot ulcers, with a special reference to multidrug resistant strains. J Clin Diagnostic Res 7:441–445. https://doi.org/10.7860/JCDR/2013/5091.2794 - DOI
-
- Schaffer JN, Pearson MM (2016) Proteus mirabilis and urinary tract infections. In: Urinary tract infections: molecular pathogenesis and clinical management. Taylor & Francis, pp 383–433
-
- O’Hara CM, Brenner FW, Miller JM (2000) Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev 13:534–546 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous